Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Healthcare Realty Trust Incorporated Common Stock (HR) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

Healthcare Realty Trust Incorporated Common StockTrade
NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Healthcare Realty Trust Incorporated Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Healthcare Realty Trust Incorporated Common Stock trades at $17 (market cap $5.90B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B). The key difference: Healthcare Realty Trust Incorporated Common Stock is far larger — about 2.8× NeoGenomics Inc. Common Stock's market cap, and Healthcare Realty Trust Incorporated Common Stock pays a 5.57% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Healthcare Realty Trust Incorporated Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

HRNEO
Market Cap
$5.90B$2.14B
Volume
4,466,6102,228,400
Sector
Real EstateHealth
52-Week High
$21.87$19.91
52-Week Low
$16.34$7.19
Typical Hold Time
0 Days0 Days
Enterprise Value
$10.29B$2.44B
Dividend Yield
5.57%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HR
100% Buy0% Sell
Avg holding period · 0 Days
NEO
100% Buy0% Sell
Avg holding period · 0 Days

About Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust Incorporated is a real estate investment trust that owns and manages outpatient medical facilities and on-campus medical office buildings across US, leasing space to physician groups, hospitals, and health systems.

Read more on HR →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →